Archive Newsletter
-
06.23.26 -- Emerging Technologies In Aseptic Processing: Hype Vs. Operational Reality
6/23/2026
06/23/26 Cell & Gene Newsletter
-
06.22.26 -- Navigating The Next Wave Of AAV Capsid
6/22/2026
06/22/26 Cell & Gene Newsletter
-
06.22.26 -- CDMO Selection: Start With The Relationship, Not The RFP
6/22/2026
06/22/26 Cell & Gene Newsletter
-
06.19.26 -- Redefining CAR-T Timing And Patient Access With Allogene Therapeutics' Dr. Zachary Roberts
6/19/2026
06/19/26
-
06.18.26 -- Tools And Technologies Enabling Next-Generation Cell Therapies
6/18/2026
06/18/26 Cell & Gene Newsletter
-
06.18.26 -- Scale Vaccine Production With Proven Cell Culture Solutions
6/18/2026
06/18/26 Cell & Gene Newsletter
-
06.18.26 -- Inside AstraZeneca's Fully Electrified Cell Therapy Facility
6/18/2026
06/18/26 Cell & Gene Newsletter
-
06.17.26 -- What's Slowing Your Cell & Gene Therapy Program?
6/17/2026
06/17/26 Cell & Gene Newsletter
-
06.17.26 -- Why Regulatory And Manufacturing Strategy Must Start Together
6/17/2026
06/17/26
-
06.16.26 -- Reduce mAb Aggregates: Practical Strategies
6/16/2026
06/16/26 Cell & Gene Newsletter